Annual EBITDA
-$9.15 M
+$94.66 M+91.19%
March 31, 2024
Summary
- As of February 7, 2025, ACB annual EBITDA is -$9.15 million, with the most recent change of +$94.66 million (+91.19%) on March 31, 2024.
- During the last 3 years, ACB annual EBITDA has risen by +$408.24 million (+97.81%).
- ACB annual EBITDA is now -111.47% below its all-time high of $79.76 million, reached on June 30, 2018.
Performance
ACB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$5.98 M
-$5.11 M-46.06%
September 1, 2024
Summary
- As of February 7, 2025, ACB quarterly EBITDA is $5.98 million, with the most recent change of -$5.11 million (-46.06%) on September 1, 2024.
- Over the past year, ACB quarterly EBITDA has increased by +$16.32 million (+157.87%).
- ACB quarterly EBITDA is now -94.13% below its all-time high of $101.94 million, reached on September 30, 2018.
Performance
ACB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$2.96 M
-$3.11 M-51.20%
September 1, 2024
Summary
- As of February 7, 2025, ACB TTM EBITDA is $2.96 million, with the most recent change of -$3.11 million (-51.20%) on September 1, 2024.
- Over the past year, ACB TTM EBITDA has increased by +$7.90 million (+159.87%).
- ACB TTM EBITDA is now -98.31% below its all-time high of $174.92 million, reached on September 30, 2018.
Performance
ACB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ACB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +91.2% | +157.9% | +159.9% |
| 3 y3 years | +97.8% | - | - |
| 5 y5 years | +94.0% | - | - |
ACB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.3% | -46.1% | +100.8% | -51.2% | +100.2% |
| 5 y | 5-year | at high | +99.6% | -72.9% | +100.5% | -51.2% | +100.1% |
| alltime | all time | -111.5% | +99.6% | -94.1% | +100.5% | -98.3% | +100.1% |
Aurora Cannabis EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5.98 M(-46.1%) | $2.96 M(-51.2%) |
| Jun 2024 | - | $11.09 M(-393.8%) | $6.07 M(-169.6%) |
| Mar 2024 | -$9.15 M(-91.2%) | -$3.77 M(-63.5%) | -$8.72 M(+76.3%) |
| Dec 2023 | - | -$10.34 M(-213.8%) | -$4.94 M(-82.1%) |
| Sep 2023 | - | $9.09 M(-346.0%) | -$27.60 M(-60.5%) |
| Jun 2023 | - | -$3.69 M(-88.8%) | -$69.87 M(-94.6%) |
| Mar 2023 | -$103.81 M(-91.5%) | - | - |
| Dec 2022 | - | -$32.99 M(-0.6%) | -$1.28 B(+0.5%) |
| Sep 2022 | - | -$33.19 M(-92.7%) | -$1.28 B(+4.5%) |
| Jun 2022 | -$1.23 B(+194.2%) | -$457.24 M(-39.9%) | -$1.22 B(+44.1%) |
| Mar 2022 | - | -$761.12 M(+2755.2%) | -$848.85 M(+357.5%) |
| Dec 2021 | - | -$26.66 M(-220.6%) | -$185.52 M(-47.4%) |
| Sep 2021 | - | $22.10 M(-126.6%) | -$352.63 M(-15.5%) |
| Jun 2021 | -$417.39 M(-82.2%) | -$83.17 M(-14.9%) | -$417.25 M(-74.9%) |
| Mar 2021 | - | -$97.79 M(-49.5%) | -$1.66 B(+0.9%) |
| Dec 2020 | - | -$193.76 M(+355.7%) | -$1.65 B(-31.8%) |
| Sep 2020 | - | -$42.52 M(-96.8%) | -$2.42 B(+4.4%) |
| Jun 2020 | -$2.35 B(+1431.6%) | -$1.33 B(+1498.0%) | -$2.32 B(+140.6%) |
| Mar 2020 | - | -$83.18 M(-91.4%) | -$963.30 M(-1.2%) |
| Dec 2019 | - | -$963.52 M(-1746.5%) | -$974.66 M(+398.5%) |
| Sep 2019 | - | $58.52 M(+135.3%) | -$195.51 M(+28.5%) |
| Jun 2019 | -$153.30 M(-292.2%) | $24.88 M(-126.3%) | -$152.10 M(+54.4%) |
| Mar 2019 | - | -$94.54 M(-48.7%) | -$98.48 M(+414.7%) |
| Dec 2018 | - | -$184.37 M(-280.9%) | -$19.14 M(-110.9%) |
| Sep 2018 | - | $101.94 M(+29.9%) | $174.92 M(+125.8%) |
| Jun 2018 | $79.76 M(-810.9%) | $78.49 M(-616.6%) | $77.46 M(-1320.1%) |
| Mar 2018 | - | -$15.19 M(-256.8%) | -$6.35 M(-165.6%) |
| Dec 2017 | - | $9.69 M(+116.7%) | $9.68 M(-495.7%) |
| Sep 2017 | - | $4.47 M(-184.1%) | -$2.45 M(-78.2%) |
| Jun 2017 | -$11.22 M(+219.2%) | -$5.32 M(-734.7%) | -$11.20 M(-3.1%) |
| Mar 2017 | - | $838.20 K(-134.4%) | -$11.56 M(+11.8%) |
| Dec 2016 | - | -$2.44 M(-43.1%) | -$10.34 M(+42.1%) |
| Sep 2016 | - | -$4.28 M(-24.6%) | -$7.27 M(+93.4%) |
| Jun 2016 | -$3.51 M | -$5.68 M(-375.4%) | -$3.76 M(-823.2%) |
| Mar 2016 | - | $2.06 M(+229.8%) | $520.10 K(-123.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | - | $625.50 K(-181.4%) | -$2.26 M(-71.4%) |
| Sep 2015 | - | -$768.00 K(-45.2%) | -$7.91 M(-1.0%) |
| Jun 2015 | -$7.91 M(+363.8%) | -$1.40 M(+95.5%) | -$7.99 M(-1.5%) |
| Mar 2015 | - | -$716.10 K(-85.7%) | -$8.11 M(+8.4%) |
| Dec 2014 | - | -$5.02 M(+491.2%) | -$7.48 M(+201.1%) |
| Sep 2014 | - | -$849.50 K(-44.1%) | -$2.48 M(+48.5%) |
| Jun 2014 | -$1.71 M(+336.5%) | -$1.52 M(+1672.3%) | -$1.67 M(+574.7%) |
| Mar 2014 | - | -$85.70 K(+193.5%) | -$247.80 K(+4.7%) |
| Dec 2013 | - | -$29.20 K(-23.4%) | -$236.60 K(-15.0%) |
| Sep 2013 | - | -$38.10 K(-59.8%) | -$278.40 K(-29.1%) |
| Jun 2013 | -$390.60 K(+18.6%) | -$94.80 K(+27.2%) | -$392.80 K(-21.1%) |
| Mar 2013 | - | -$74.50 K(+4.9%) | -$497.70 K(+6.3%) |
| Dec 2012 | - | -$71.00 K(-53.4%) | -$468.30 K(+7.6%) |
| Sep 2012 | - | -$152.50 K(-23.6%) | -$435.30 K(+34.2%) |
| Jun 2012 | -$329.30 K(+11.5%) | -$199.70 K(+342.8%) | -$324.30 K(+164.5%) |
| Mar 2012 | - | -$45.10 K(+18.7%) | -$122.60 K(-59.3%) |
| Dec 2011 | - | -$38.00 K(-8.4%) | -$301.20 K(-2.9%) |
| Sep 2011 | - | -$41.50 K(-2175.0%) | -$310.30 K(+1.7%) |
| Jun 2011 | -$295.40 K(+627.6%) | $2000.00(-100.9%) | -$305.00 K(-13.6%) |
| Mar 2011 | - | -$223.70 K(+374.9%) | -$353.10 K(+128.4%) |
| Dec 2010 | - | -$47.10 K(+30.1%) | -$154.60 K(+32.2%) |
| Sep 2010 | - | -$36.20 K(-21.5%) | -$116.90 K(+13.2%) |
| Jun 2010 | -$40.60 K(-74.6%) | -$46.10 K(+82.9%) | -$103.30 K(-3.6%) |
| Mar 2010 | - | -$25.20 K(+168.1%) | -$107.20 K(+1.5%) |
| Dec 2009 | - | -$9400.00(-58.4%) | -$105.60 K(-13.9%) |
| Sep 2009 | - | -$22.60 K(-54.8%) | -$122.70 K(-34.9%) |
| Jun 2009 | -$159.90 K(-8.6%) | -$50.00 K(+111.9%) | -$188.60 K(+17.4%) |
| Mar 2009 | - | -$23.60 K(-10.9%) | -$160.60 K(+13.6%) |
| Dec 2008 | - | -$26.50 K(-70.1%) | -$141.40 K(-50.1%) |
| Sep 2008 | - | -$88.50 K(+302.3%) | -$283.20 K(+44.4%) |
| Jun 2008 | -$174.90 K(>+9900.0%) | -$22.00 K(+400.0%) | -$196.10 K(+12.6%) |
| Mar 2008 | - | -$4400.00(-97.4%) | -$174.10 K(+2.6%) |
| Dec 2007 | - | -$168.30 K(>+9900.0%) | -$169.70 K(>+9900.0%) |
| Sep 2007 | - | -$1400.00 | -$1400.00 |
| Jun 2007 | -$1100.00 | - | - |
FAQ
- What is Aurora Cannabis annual EBITDA?
- What is the all time high annual EBITDA for Aurora Cannabis?
- What is Aurora Cannabis annual EBITDA year-on-year change?
- What is Aurora Cannabis quarterly EBITDA?
- What is the all time high quarterly EBITDA for Aurora Cannabis?
- What is Aurora Cannabis quarterly EBITDA year-on-year change?
- What is Aurora Cannabis TTM EBITDA?
- What is the all time high TTM EBITDA for Aurora Cannabis?
- What is Aurora Cannabis TTM EBITDA year-on-year change?
What is Aurora Cannabis annual EBITDA?
The current annual EBITDA of ACB is -$9.15 M
What is the all time high annual EBITDA for Aurora Cannabis?
Aurora Cannabis all-time high annual EBITDA is $79.76 M
What is Aurora Cannabis annual EBITDA year-on-year change?
Over the past year, ACB annual EBITDA has changed by +$94.66 M (+91.19%)
What is Aurora Cannabis quarterly EBITDA?
The current quarterly EBITDA of ACB is $5.98 M
What is the all time high quarterly EBITDA for Aurora Cannabis?
Aurora Cannabis all-time high quarterly EBITDA is $101.94 M
What is Aurora Cannabis quarterly EBITDA year-on-year change?
Over the past year, ACB quarterly EBITDA has changed by +$16.32 M (+157.87%)
What is Aurora Cannabis TTM EBITDA?
The current TTM EBITDA of ACB is $2.96 M
What is the all time high TTM EBITDA for Aurora Cannabis?
Aurora Cannabis all-time high TTM EBITDA is $174.92 M
What is Aurora Cannabis TTM EBITDA year-on-year change?
Over the past year, ACB TTM EBITDA has changed by +$7.90 M (+159.87%)